ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
유전자 이식 시장 규모는 최근 급속도로 확대되고 있습니다. 2024년 36억 5,000만 달러에서 2025년에는 41억 3,000만 달러에 달하고, CAGR 13.3%로 확대될 전망입니다. 실적기간 내 성장은 초기 임상시험의 성공률 증가, 차세대 시퀀싱(NGS) 채용 확대, 세포 기반 치료법 개발 증가, 희소질환용 의약품 지정의 이용 가능성 확대에 의해 발생하였습니다.
유전자 이식 시장 규모는 향후 수년간 급성장할 것으로 전망됩니다. 2029년에는 CAGR 12.9%로 67억 2,000만 달러로 성장할 전망입니다. 예측 기간 내 성장은 일회성 치료에 대한 관심 증가, 유전자 치료의 생산 능력 확대, 규제 조화의 진전, 신경질환에 대한 응용 증가, 합성 생물학적 플랫폼의 이용 확대 등과 관련이 있습니다. 예측 기간 중의 주요 동향으로는 유전자 편집 플랫폼과 인공지능의 통합, 유전자 치료와 재생 의료의 조합, 유전자 치료 시험에서의 웨어러블 바이오 센서의 사용, 유전자 변형 세포를 이용한 3D 바이오프린팅의 응용, 임상 데이터 관리에 있어서의 블록체인 임베딩 등을 들 수 있습니다.
유전자 치료의 성장은 향후 수년간 유전자 이식 시장의 확대를 이끌 것으로 예측됩니다. 유전자 치료는 질병의 예방과 치료를 위해 사람의 유전자를 변형시키는 기술입니다. 이 분야는 안전하고 효율적으로 표적을 정하고 유전자 물질을 세포 내로 전달하는 전달 시스템의 진보에 의해 성장하고 있습니다. 유전자 치료는 결함이 있는 유전자를 수정하거나 대체하는 표적 치료를 제공함으로써 유전성 질환의 관리에 중요한 역할을 하고 있으며, 과거에는 치료가 불가능했던 질병에 대한 해결책을 제공합니다. 질병의 근본 원인을 해결함으로써 유전자 치료는 증상을 완화하고 질병 진행을 멈추며 궁극적으로 환자의 예후와 삶의 질을 향상시키는 데 도움이 됩니다. 예를 들어, 미국 유전자 세포 치료 학회(ASGCT)는 2024년 12월, FDA가 2023년에 승인한 유전자 치료 제품은 6개였으며, 2022년 5개에서 증가했다고 보고했습니다. 따라서, 유전자 치료 증가가 유전자 이식 시장의 성장을 가속화하고 있습니다.
유전자 이식 시장의 주요 기업은 유전자 치료 효율, 정확성 및 속도를 높이기 위해 자동 복제 플랫폼과 같은 첨단 기술 개발에 주력하고 있습니다. 자동 복제 플랫폼은 단일 세포를 단일 클론 라인으로 분리하고 배양하는 시스템으로 유전자 이식 및 치료 절차의 속도, 일관성 및 정확성을 향상시킵니다. 예를 들어, 2024년 11월 영국의 생명 과학 기술 기업인 iotaSciences는 XT Single-Cell Cloning Platform을 발표했습니다. 이 플랫폼은 자동 마이크로플루이딕스공학, 인공지능에 의한 영상 분석, 나노분주 기술을 통합하여 개별 세포의 높은 처리량과 정확한 분리를 가능하게 합니다. 유전자 치료 개발을 가속화하기 위해 설계된 이 시스템은 단일 클론성을 보장하고, 중요한 규제 요건인 처리 시간을 수주에서 수일로 단축합니다. 이 시스템은 또한 편집 성분을 표적 세포에 효율적으로 전달함으로써 CRISPR 기반 유전자 편집을 지원하고 차세대 요법의 개발을 촉진합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 유전자 이식 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 유전자 이식 시장 : 성장률 분석
세계의 유전자 이식 시장 실적 : 규모와 성장(2019-2024년)
세계의 유전자 이식 시장 예측 : 규모와 성장(2024-2029년, 2034년)
세계의 유전자 이식 : 총 시장 규모(TAM)
제6장 시장 세분화
세계의 유전자 이식 시장 : 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
자가
동종
세계의 유전자 이식 시장 : 용도별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
유전질환
암
희귀질환
기타 용도
세계의 유전자 이식 시장 : 최종 사용자별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
병원
연구기관
생명공학 기업
기타 최종 사용자
세계의 유전자 이식 시장 세분화 : 자가 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
조혈 줄기 세포 이식
유전자 변형 자기 세포 요법
키메라 항원 수용체 T(CAR-T) 세포 요법
세계의 유전자 이식 시장 세분화 : 동종 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
조혈 줄기 세포 이식
유전자변형 동종 세포 요법
동종 키메라 항원 수용체 T(CAR-T) 세포 요법
기제품 유전자 치료
제7장 지역별/국가별 분석
세계의 유전자 이식 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세계의 유전자 이식 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
유전자 이식 시장 : 경쟁 구도
유전자 이식 시장 : 기업 프로파일
Bayer AG : 개요, 제품 및 서비스, 전략 및 재무 분석
Novartis AG : 개요, 제품 및 서비스, 전략 및 재무 분석
CSL Behring LLC : 개요, 제품 및 서비스, 전략 및 재무 분석
Charles River Laboratories International Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
BioMarin Pharmaceutical Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Sarepta Therapeutics Inc.
Ultragenyx Pharmaceutical Inc.
CRISPR Therapeutics AG
Beam Therapeutics Inc.
Rocket Pharmaceuticals Inc.
Voyager Therapeutics Inc.
Sangamo Therapeutics Inc.
Editas Medicine Inc.
Krystal Biotech Inc.
bluebird bio Inc.
Orchard Therapeutics plc
4D Molecular Therapeutics Inc.
Solid Biosciences Inc.
uniQure NV
MeiraGTx Holdings plc
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
유전자 이식 시장(2029년) : 새로운 기회를 제공하는 국가
유전자 이식 시장(2029년) : 새로운 기회를 제공하는 부문
유전자 이식 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
CSM
영문 목차
영문목차
Gene transplant refers to the process of introducing healthy or modified genes into a patient's cells to replace or repair defective genes responsible for disease. Its primary goal is to correct genetic disorders, restore normal cellular function, or provide therapeutic effects, such as enhancing the immune system's ability to target diseases.
The primary types of gene transplant are autologous and allogeneic. Autologous involves collecting a patient's own cells, genetically modifying them, and transplanting them back into the same individual to treat or prevent disease. Applications include genetic disorders, cancer, rare diseases, and more, serving hospitals, research institutions, biotechnology companies, and other end users.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.
The gene transplant market research report is one of a series of new reports from The Business Research Company that provides gene transplant market statistics, including the gene transplant industry global market size, regional shares, competitors with the gene transplant market share, detailed gene transplant market segments, market trends, and opportunities, and any further data you may need to thrive in the gene transplant industry. This gene transplant market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The gene transplant market size has grown rapidly in recent years. It will grow from $3.65 billion in 2024 to $4.13 billion in 2025 at a compound annual growth rate (CAGR) of 13.3%. The growth in the historic period can be linked to rising success rates in early clinical trials, greater adoption of next-generation sequencing (NGS), increased development of cell-based therapies, and wider availability of orphan drug designations.
The gene transplant market size is expected to see rapid growth in the next few years. It will grow to $6.72 billion in 2029 at a compound annual growth rate (CAGR) of 12.9%. The growth in the forecast period can be linked to heightened focus on one-time curative treatments, expansion of manufacturing capacity for gene therapies, growing regulatory harmonization, increasing applications in neurological disorders, and greater use of synthetic biology platforms. Key trends during the forecast period include integration of artificial intelligence with gene editing platforms, combination of gene therapy with regenerative medicine, use of wearable biosensors in gene therapy trials, application of 3D bioprinting with gene-modified cells, and incorporation of blockchain in clinical data management.
The growth of gene therapy is expected to drive the expansion of the gene transplant market in the coming years. Gene therapy is a technique that alters a person's genes to prevent or treat diseases. This field is growing due to advancements in delivery systems, which allow for the safe, efficient, and targeted transport of genetic material into cells. Gene therapy plays a key role in managing genetic disorders by offering targeted treatments that can correct or replace defective genes, providing solutions for conditions that were once untreatable. By addressing the root cause of diseases, gene therapy helps reduce symptoms and halt disease progression, ultimately improving patient outcomes and quality of life. For example, the American Society of Gene & Cell Therapy (ASGCT) reported in December 2024 that the FDA approved six gene therapy products in 2023, an increase from five approvals in 2022. As a result, the rise in gene therapy is accelerating the growth of the gene transplant market.
Key players in the gene transplant market are focusing on the development of advanced technologies, such as automated cloning platforms, to enhance the efficiency, precision, and speed of gene therapy. Automated cloning platforms are systems that isolate and culture single cells into monoclonal lines, improving the speed, consistency, and accuracy of gene transplant and therapy procedures. For instance, in November 2024, iotaSciences Ltd., a UK-based life sciences technology company, launched the XT Single-Cell Cloning Platform. This platform integrates automated microfluidics, AI-driven image analysis, and nano-dispensing technology, enabling high-throughput and precise isolation of individual cells. Designed to accelerate gene therapy development, it ensures monoclonality-a key regulatory requirement-while reducing processing time from weeks to days. This system also supports CRISPR-based gene editing by efficiently delivering editing components to target cells, thus advancing the development of next-generation therapies.
In January 2025, Roche, a Swiss pharmaceutical company, expanded its capabilities by acquiring Poseida Therapeutics Inc. for $1.5 billion. This acquisition strengthens Roche's gene transplant and cell therapy portfolio by giving it access to Poseida's non-viral gene editing and delivery technologies, which are designed to treat genetic disorders and cancers. Poseida Therapeutics Inc. is a US-based company focused on developing gene transplant therapies.
Major players in the gene transplant market are Bayer AG, Novartis AG, CSL Behring LLC, Charles River Laboratories International Inc., BioMarin Pharmaceutical Inc., Sarepta Therapeutics Inc., Ultragenyx Pharmaceutical Inc., CRISPR Therapeutics AG, Beam Therapeutics Inc., Rocket Pharmaceuticals Inc., Voyager Therapeutics Inc., Sangamo Therapeutics Inc., Editas Medicine Inc., Krystal Biotech Inc., bluebird bio Inc., Orchard Therapeutics plc, 4D Molecular Therapeutics Inc., Solid Biosciences Inc., uniQure N.V., and MeiraGTx Holdings plc.
North America was the largest region in the gene transplant market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in gene transplant report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the gene transplant market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The gene transplant market includes revenues earned by entities through gene therapy consultation, genetic engineering, cell processing and modification, vector delivery services, clinical trial support, and patient-specific treatment administration. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Gene Transplant Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on gene transplant market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for gene transplant ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The gene transplant market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Type: Autologous; Allogeneic
2) By Application: Genetic Disorders; Cancer; Rare Diseases; Other Application
3) By End-User: Hospitals; Research Institutes; Biotechnology Companies; Other End-Users
Subsegments:
1) By Autologous: Hematopoietic Stem Cell Transplantation; Gene-Modified Autologous Cell Therapy; Chimeric Antigen Receptor T (CAR-T) Cell Therapy
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Gene Transplant Market Characteristics
3. Gene Transplant Market Trends And Strategies
4. Gene Transplant Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Gene Transplant Growth Analysis And Strategic Analysis Framework
5.1. Global Gene Transplant PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Gene Transplant Market Growth Rate Analysis
5.4. Global Gene Transplant Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Gene Transplant Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Gene Transplant Total Addressable Market (TAM)
6. Gene Transplant Market Segmentation
6.1. Global Gene Transplant Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Autologous
Allogeneic
6.2. Global Gene Transplant Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Genetic Disorders
Cancer
Rare Diseases
Other Applications
6.3. Global Gene Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Research Institutes
Biotechnology Companies
Other End-Users
6.4. Global Gene Transplant Market, Sub-Segmentation Of Autologous, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hematopoietic Stem Cell Transplantation
Gene-Modified Autologous Cell Therapy
Chimeric Antigen Receptor T (CAR-T) Cell Therapy
6.5. Global Gene Transplant Market, Sub-Segmentation Of Allogeneic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hematopoietic Stem Cell Transplantation
Gene-Modified Allogeneic Cell Therapy
Allogeneic Chimeric Antigen Receptor T (CAR-T) Cell Therapy
Off-The-Shelf Gene Therapies
7. Gene Transplant Market Regional And Country Analysis
7.1. Global Gene Transplant Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Gene Transplant Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Gene Transplant Market
8.1. Asia-Pacific Gene Transplant Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Gene Transplant Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Gene Transplant Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Gene Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Gene Transplant Market
9.1. China Gene Transplant Market Overview
9.2. China Gene Transplant Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Gene Transplant Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Gene Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Gene Transplant Market
10.1. India Gene Transplant Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Gene Transplant Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Gene Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Gene Transplant Market
11.1. Japan Gene Transplant Market Overview
11.2. Japan Gene Transplant Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Gene Transplant Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Gene Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Gene Transplant Market
12.1. Australia Gene Transplant Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Gene Transplant Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Gene Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Gene Transplant Market
13.1. Indonesia Gene Transplant Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Gene Transplant Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Gene Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Gene Transplant Market
14.1. South Korea Gene Transplant Market Overview
14.2. South Korea Gene Transplant Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Gene Transplant Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Gene Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Gene Transplant Market
15.1. Western Europe Gene Transplant Market Overview
15.2. Western Europe Gene Transplant Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Gene Transplant Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Gene Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Gene Transplant Market
16.1. UK Gene Transplant Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Gene Transplant Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Gene Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Gene Transplant Market
17.1. Germany Gene Transplant Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Gene Transplant Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Gene Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Gene Transplant Market
18.1. France Gene Transplant Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Gene Transplant Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Gene Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Gene Transplant Market
19.1. Italy Gene Transplant Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Gene Transplant Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Gene Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Gene Transplant Market
20.1. Spain Gene Transplant Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Gene Transplant Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Gene Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Gene Transplant Market
21.1. Eastern Europe Gene Transplant Market Overview
21.2. Eastern Europe Gene Transplant Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Gene Transplant Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Gene Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Gene Transplant Market
22.1. Russia Gene Transplant Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Gene Transplant Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Gene Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Gene Transplant Market
23.1. North America Gene Transplant Market Overview
23.2. North America Gene Transplant Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Gene Transplant Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Gene Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Gene Transplant Market
24.1. USA Gene Transplant Market Overview
24.2. USA Gene Transplant Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Gene Transplant Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Gene Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Gene Transplant Market
25.1. Canada Gene Transplant Market Overview
25.2. Canada Gene Transplant Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Gene Transplant Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Gene Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Gene Transplant Market
26.1. South America Gene Transplant Market Overview
26.2. South America Gene Transplant Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Gene Transplant Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Gene Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Gene Transplant Market
27.1. Brazil Gene Transplant Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Gene Transplant Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Gene Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Gene Transplant Market
28.1. Middle East Gene Transplant Market Overview
28.2. Middle East Gene Transplant Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Gene Transplant Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Gene Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Gene Transplant Market
29.1. Africa Gene Transplant Market Overview
29.2. Africa Gene Transplant Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Gene Transplant Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Gene Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Gene Transplant Market Competitive Landscape And Company Profiles
